Effects of Pre-Dosage Alendronate Treatment on Bone Metabolic Indices and Bone Mineral Density in Patients Treated with Glucocorticoids: A Prospective Study

被引：0
|
作者：
Kuroki, Yasuo [1 ]
Kaji, Hiroshi [2 ]
Yamauchi, Mika [3 ]
Sugimoto, Toshitsugu [4 ]
机构：
[1] Kobe Century Mem Hosp, Kobe, Hyogo, Japan
[2] Kinki Univ, Fac Med, Osakasayama, Japan
[3] Shimane Univ, Fac Med, Izmo, Japan
[4] Shimane Univ, Fac Med, Izumo, Shimane, Japan
来源：
ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2256
引用
收藏
页码：S982 / S982
页数：1
相关论文
共 50 条
  • [31] Bone mineral density in patients with metabolic syndrome
    Giorgadze, E
    Tsagareli, M
    Jikurauli, N
    Tsagareli, N
    Korinteli, M
    Svani, N
    INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S168 - S168
  • [32] Osteoporosis: Treatment with etidronate and alendronate-comparative study on bone mineral density and fracture
    Rajan, KT
    Griffiths, J
    Williams, J
    Price'Lloyd, N
    Martin, J
    Morgan, J
    BONE, 2003, 32 (05) : S205 - S205
  • [33] The usefulness of bone metabolic indices for the prediction of changes in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism
    Kaji, H.
    Nomura, R.
    Yamauchi, M.
    Chihara, K.
    Sugimoto, T.
    HORMONE AND METABOLIC RESEARCH, 2006, 38 (06) : 411 - 416
  • [34] Effects of elevated serum prolactin on bone mineral density and bone metabolism in female patients with schizophrenia: A prospective study
    Abraham, G
    Paing, WW
    Kaminski, J
    Joseph, A
    Kohegyi, E
    Josiassen, RC
    AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (09): : 1618 - 1620
  • [35] Bone mineral density in patients treated with antipsychotics
    Cengiz, Arzu
    Altinyazar, Vesile
    Manoglu, Burcukin Gulun
    Vahapoglu, Fatih
    Kocabas, Oktay
    Omurlu, Imran Kurt
    Yurekli, Yakup
    ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY, 2019, 20 (02): : 182 - 188
  • [36] Bone Mineral Density in Patients Treated with Antipsychotics
    Cengiz, A.
    Altinyazar, V.
    Manoglu, B. G.
    Vahapoglu, F.
    Kocabas, O.
    Omurlu, I. Kurt
    Yurekli, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S784 - S785
  • [37] Treatment with hydrochlorothiazide and alendronate in patients with stones and bone mineral density loss. Evolution of bone metabolism and calciuria with medical treatment
    Arrabal-Martin, Miguel
    Gonzalez-Torres, Samuel
    del Carmen Cano-Garcia, Maria
    Poyatos-Andujar, Antonio
    Abad-Menor, Felix
    Angel Arrabal-Polo, Miguel
    ARCHIVOS ESPANOLES DE UROLOGIA, 2016, 69 (01): : 9 - 18
  • [38] Comparison of bone and total alkaline phosphatase and bone mineral density in postmenopausal osteoporotic women treated with alendronate
    Watts, NB
    Jenkins, DK
    Visor, JM
    Casal, DC
    Geusens, P
    OSTEOPOROSIS INTERNATIONAL, 2001, 12 (04) : 279 - 288
  • [39] Comparison of Bone and Total Alkaline Phosphatase and Bone Mineral Density in Postmenopausal Osteoporotic Women Treated with Alendronate
    N. B. Watts
    D. K. Jenkins
    J. M. Visor
    D. C. Casal
    P. Geusens
    Osteoporosis International, 2001, 12 : 279 - 288
  • [40] Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone mass
    Felsenberg, D.
    Bock, O.
    Boerst, H.
    Armbrecht, G.
    Beller, G.
    Degner, C.
    Stephan-Oelkers, M.
    Schacht, E.
    Mazor, Z.
    Hashimoto, J.
    Roth, H-J.
    Martus, P.
    Runge, M.
    JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS, 2011, 11 (01) : 34 - 45
12345